Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

D Stolz, T Mkorombindo, DM Schumann, A Agusti… - The Lancet, 2022 - thelancet.com
Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

[HTML][HTML] The role of oxidative stress and antioxidants in cardiovascular comorbidities in COPD

Z Miklós, I Horváth - Antioxidants, 2023 - mdpi.com
Oxidative stress driven by several environmental and local airway factors associated with
chronic obstructive bronchiolitis, a hallmark feature of COPD, plays a crucial role in disease …

Inhibition of oxidative stress by apocynin attenuated chronic obstructive pulmonary disease progression and vascular injury by cigarette smoke exposure

SMH Chan, K Brassington… - British Journal of …, 2023 - Wiley Online Library
Background and Purpose Cardiovascular disease affects up to half of the patients with
chronic obstructive pulmonary disease (COPD), exerting deleterious impact on health …

Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndrome

A Sanchez-Azofra, W Gu, JA Masso-Silva… - Journal of Clinical …, 2023 - jcsm.aasm.org
Study Objectives: The coexistence of obstructive sleep apnea (OSA) and chronic obstructive
pulmonary disease (COPD) in a single individual, also known as overlap syndrome (OVS) …

[HTML][HTML] Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease

XF Li, CQ Wan, YM Mao - Frontiers in Medicine, 2022 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) is a disease characterized by persistent
airflow limitation, and is associated with abnormal inflammatory responses in the lungs to …

[HTML][HTML] Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy

A Papaporfyriou, K Bartziokas, D Gompelmann… - Life, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of
mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only …

[HTML][HTML] Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease

NM Hawkins, C Nordon, K Rhodes, M Talukdar… - Heart, 2024 - heart.bmj.com
Objective To examine the risk of adverse cardiovascular (CV) events following an
exacerbation of chronic obstructive pulmonary disease (COPD). Methods This retrospective …

Temporal Risk of Non-Fatal Cardiovascular Events Post COPD Exacerbation: A Population-based Study

EL Graul, C Nordon, K Rhodes, J Marshall… - American Journal of …, 2023 - atsjournals.org
Rationale: Cardiovascular events following COPD exacerbations are recognised. Studies to
date have been post-hoc analyses of trials, did not differentiate exacerbation severity …

Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD

P Ellis, E Bailey, R Choate, KE Holm… - … Journal of Chronic …, 2024 - Taylor & Francis
Aim Alpha-1 antitrypsin deficiency is an autosomal co-dominant condition that predisposes
individuals to early-onset emphysema. As with COPD, AATD-COPD is associated with …

Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice

T Maeda, MT Dransfield - Current Opinion in Pulmonary Medicine, 2024 - journals.lww.com
COPD and cardiovascular disease have complicated interrelationships. Further mechanistic
studies may lead to defining better targets for interventions. Education for medical …